Intensive insulin therapy protects the endothelium of critically ill patients.
暂无分享,去创建一个
Ilse Vanhorebeek | Kristin Skogstrand | G. Van den Berghe | I. Vanhorebeek | T. Hansen | L. Langouche | Greet Van den Berghe | Pieter J Wouters | D. Vlasselaers | K. Skogstrand | Dirk Vlasselaers | P. Wouters | Lies Langouche | Sarah Vander Perre | Troels K Hansen | S. Vander Perre
[1] C. Wolf‐peeters,et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.
[2] Greet Van den Berghe,et al. How does blood glucose control with insulin save lives in intensive care , 2004 .
[3] P. Jałowiecki,et al. Serum interleukin-10 in ICU patients with severe acute central nervous system injuries , 2004, Inflammation Research.
[4] F. Aktan. iNOS-mediated nitric oxide production and its regulation. , 2004, Life sciences.
[5] D. Grimm,et al. Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. , 2004, Burns : journal of the International Society for Burn Injuries.
[6] Yoko Ishiwata,et al. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. , 2004, Metabolism: clinical and experimental.
[7] A. Aljada,et al. Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect , 2004 .
[8] Devjit Tripathy,et al. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. , 2004, Metabolism: clinical and experimental.
[9] J. Bakker,et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* , 2004, Critical care medicine.
[10] A. Aljada,et al. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. , 2003, Diabetes care.
[11] G. Van den Berghe,et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.
[12] A. Rawlingson. Nitric oxide, inflammation and acute burn injury. , 2003, Burns : journal of the International Society for Burn Injuries.
[13] C. Mantzoros,et al. Association of Proinflammatory Molecules with Apoptotic Markers and Survival in Critically Ill Multiple Organ Dysfunction Patients , 2003, Biological research for nursing.
[14] L. Olson,et al. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury , 2003, Neuroscience.
[15] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[16] P. Giannoudis,et al. Current concepts of the inflammatory response after major trauma: an update. , 2003, Injury.
[17] W. Aird. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. , 2003, Blood.
[18] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[19] B. Vallet. Bench-to-bedside review: Endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? , 2003, Critical care.
[20] M. Radomski,et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Bonnefont-Rousselot. Glucose and reactive oxygen species , 2002, Current opinion in clinical nutrition and metabolic care.
[22] U. Förstermann,et al. Physiological mechanisms regulating the expression of endothelial-type NO synthase. , 2002, Nitric oxide : biology and chemistry.
[23] John Land,et al. Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.
[24] A. Aljada,et al. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. , 2002, Metabolism: clinical and experimental.
[25] G. Van den Berghe,et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.
[26] M. Brownlee. Insight Review Articles , 2022 .
[27] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[28] D. Thickett,et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.
[29] A. Aljada,et al. Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .
[30] Y. Mao,et al. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade , 2001, Critical care medicine.
[31] Xiaodong Feng,et al. Angiogenesis in wound healing. , 2000, The journal of investigative dermatology. Symposium proceedings.
[32] F. Cipollone,et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[33] S. Wisniewski,et al. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure , 2000, Critical care medicine.
[34] I. West. Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[35] S. Lazzi,et al. Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. , 2000, American journal of respiratory and critical care medicine.
[36] C. Kahn,et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.
[37] A. Aljada,et al. Effect of insulin on human aortic endothelial nitric oxide synthase. , 2000, Metabolism: clinical and experimental.
[38] A. M. Lefer,et al. Vascular endothelial growth factor attenuates trauma‐induced injury in rats , 2000, British journal of pharmacology.
[39] N R Webster,et al. Increased mortality associated with growth hormone treatment in critically ill adults. , 1999, The New England journal of medicine.
[40] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[41] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] T. Lue,et al. Analysis of neuronal nitric oxide synthase isoform expression and identification of human nNOS-mu. , 1998, Biochemical and biophysical research communications.
[43] S. Grad,et al. Strongly Enhanced Serum Levels of Vascular Endothelial Growth Factor (VEGF) after Poly-trauma and Burn , 1998, Clinical chemistry and laboratory medicine.
[44] J. Jais,et al. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. , 1998, American journal of respiratory and critical care medicine.
[45] C. Sessler,et al. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. , 1997, American journal of respiratory and critical care medicine.
[46] P. Parsons,et al. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. , 1997, American journal of respiratory and critical care medicine.
[47] G. Giovannoni,et al. Adaptation of the Nitrate Reductase and Griess Reaction Methods for the Measurement of Serum Nitrate plus Nitrite Levels , 1997, Annals of clinical biochemistry.
[48] P. Nibbering,et al. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. , 1997, Cytokine.
[49] G. Paolisso,et al. Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.
[50] C. Thiemermann,et al. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase , 1995, British journal of pharmacology.
[51] C. Sessler,et al. Circulating ICAM-1 is increased in septic shock. , 1995, American journal of respiratory and critical care medicine.
[52] G. Hempelmann,et al. Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? , 1995, Chest.
[53] D. Heney,et al. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study , 1994, Critical care medicine.
[54] A. Baldwin,et al. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. , 1993, Genes & development.
[55] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.
[56] T. V. Gopal,et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. , 1993, Journal of immunology.
[57] J. Hevel,et al. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. , 1991, The Journal of biological chemistry.
[58] A. M. Lefer,et al. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. , 1991, The Journal of clinical investigation.
[59] J. Adams,et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.
[60] R. Dean,et al. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.
[61] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[62] Dieter Mesotten,et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[63] F. Aktan. Aktan, F.: iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639-653 , 2004 .
[64] A. Aljada,et al. Insulin as an anti-inflammatory and antiatherosclerotic hormone. , 2003, Clinical cornerstone.
[65] W. Schaufeli,et al. Simplified Therapeutic Intervention Scoring System: the TISS-28 items--results from a multicenter study. , 1996 .
[66] S. Moncada,et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. , 1994, Cardiovascular research.
[67] J. Adams,et al. hypotension: Implications for the involvement of nitric oxide , 2022 .
[68] G. Van den Berghe,et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. , 2002, The Journal of clinical endocrinology and metabolism.